Replacing Nisoldipine ER for Hypertension Management
Amlodipine is the most appropriate replacement for Nisoldipine ER in the management of hypertension. 1
Rationale for Recommendation
- Nisoldipine is a dihydropyridine calcium channel blocker (CCB) used for hypertension management 1
- Amlodipine is the preferred alternative as it:
Dosing Conversion Guidelines
- For patients on Nisoldipine ER 10-20 mg daily, start with Amlodipine 5 mg once daily 1, 3
- For patients on Nisoldipine ER 30-40 mg daily, start with Amlodipine 10 mg once daily 3
- Monitor blood pressure after conversion and adjust dose as needed 3
- Amlodipine's dosing range is 2.5-10 mg once daily 1
Other Potential Alternatives
Other Dihydropyridine CCBs
- Nifedipine long-acting/extended-release (30-60 mg once daily) is another option but requires careful product selection to ensure extended-release properties 1, 4
- Felodipine (2.5-10 mg once daily) can also be considered 1
Non-dihydropyridine CCBs
- Diltiazem ER (120-360 mg once daily) or Verapamil SR (120-360 mg daily) could be alternatives, but they have different pharmacological profiles with more pronounced effects on heart rate and cardiac conduction 1
- These should be avoided in patients with heart failure with reduced ejection fraction 1
Important Considerations
- Avoid switching to short-acting CCBs like immediate-release nifedipine due to risk of reflex tachycardia and unpredictable blood pressure fluctuations 1, 5
- If CCBs are not tolerated or contraindicated, consider other antihypertensive classes based on the 2017 ACC/AHA guidelines 1:
Monitoring After Medication Change
- Check blood pressure within 1-2 weeks after switching medications 3
- Monitor for common side effects of amlodipine including peripheral edema, headache, and flushing 2, 4
- Amlodipine is generally better tolerated than nifedipine with fewer side effects 2
- Ensure continued avoidance of medications that can exacerbate hypertension, such as decongestants containing pseudoephedrine or phenylephrine 6
Special Populations
- In patients with heart failure, amlodipine is preferred over other CCBs 1
- In elderly patients, consider starting with a lower dose (2.5 mg) of amlodipine 1
- For patients with resistant hypertension, adding a mineralocorticoid receptor antagonist may be beneficial if changing to amlodipine does not provide adequate control 1